Presence of any one of following abnormal criteria of either: 1) Cardio-specific Biomarker; 2) Abnormal elevated value of plasma Gb3 or Lyso-Gb3; 3) Electrocardiography (ECG); 4) Cardio-specific Image.
Group A: ERT Treatment naïve Fabry patients
Group B: Agalsidase beta (ERT) exposed or treated Fabry patients
Willing and able to comply with the required clinic visits, study procedures and assessments
You may not be if
Patient who are unwilling to sign inform consent form